RNTX · Rein Therapeutics, Inc.
Market Cap
$64.56M
Shares
86.27M
Volume · Oct 6
141.02K
Avg daily vol (3M)
423.65K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.83
Open$0.81
Day$0.81–0.87
52W close$0.70–1.88
Avg vol 30d397K
Short int671K · 0.8% float · 1.4d
Short vol40%
DataJan 2020–Oct 2026
Filing10-Q · Aug 14
Up next
filed Aug 14, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$0
Trailing 12 months
Net income (TTM)
−$49.76M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$40.65M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+177.4%
Year over year · more shares
Price change (1Y)
-30.7%
Trailing year
Short interest
0.8%
Latest settlement · 1.4 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 15.5 · calm
Equity put/call 0.59
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−24%
below
Price vs 50-day avg
+5%
above
RSI (14)
54
neutral
MACD trend
Positive
52-week position
10%
near low
Momentum
relative strength
1-month return
−7%
trailing
6-month return
−49%
trailing
YTD return
−29%
this year
Relative strength
−61%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+28% holders QoQ · +21 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.78% of float · ▲ +4.3% MoM · 1.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
59 holders — near 3-yr high, broad support
Squeeze score
45
elevated · 0–100
Fundamentals
EPS growth
+44%
Y/Y
Free cash flow
$-19.5M
Quant / Vol
risk profile
Volatility
87%
annualized · 1-yr
Max drawdown
−63%
past year
ATR
8.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−24%
Bearish
Price vs 50-day avg
+5%
Bullish
RSI (14)
54
Neutral
MACD trend
Positive
Bullish
52-week position
10%
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+28% holders QoQ · +21 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.78% of float · ▲ +4.3% MoM · 1.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
59 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $1
Now $1 · 10%
Range high $2
vs 200-day avg -24%
vs 50-day avg +5%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RNTX
this stock
Rein Therapeutics, Inc.
|
$64.56M | -28.9% | — | — | 0.8% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$133.37B | +11.1% | +46.2% | 30.7 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$81.13B | -5.9% | +20.8% | 19.5 | 2.5% |
|
MRNA
Moderna, Inc.
|
$79.40B | +589.1% | +4.3% | — | 8.2% |
|
CSLLY
Csl Ltd
|
$61.25B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RNTX | +14.4% | -7.2% | -49.4% | +2.6% | -28.9% |
| SPY | +1.2% | +0.6% | +11.6% | +1.6% | +13.6% |
| vs SPY | +13.2% | -7.8% | -61.0% | +1.0% | -42.5% |